This collection of official Santa Clara University logos reflects the institution's identity, values, and traditions. They are essential to maintaining a consistent brand presence. Please use them ...
Keros Therapeutics KROS is focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming ...
Can an athlete logo contain multitudes? Can a monochromatic mark somehow capture all the glory of a basketball player’s achievements, the verve of a charismatic tennis star, or celly after a scored ...
For millions, purchasing a vehicle is one of the most significant transactions most people will ever make. So not only must new vehicles meet every safety and governmental regulation, but getting the ...
Dyne Therapeutics leverages its FORCE platform to target genetically driven muscle diseases with two lead clinical programs approaching pivotal milestones. DYNE-101 shows strong safety and functional ...
Sarepta Therapeutics has terminated a Phase I trial evaluating its gene therapy Elevidys (delandistrogene moxeparvovec) in combination with Hansa Biopharma’s Idefirix (imlifidase). The study ...
Sarepta Therapeutics, Inc. SRPT reported fourth-quarter 2024 earnings per share (EPS) of $1.50, which missed the Zacks Consensus Estimate of $1.87. However, the reported figure was significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results